Preclinical assessment of candidate analgesic drugs: Recent advances and future challenges

Journal of Pharmacology and Experimental Therapeutics

Volumn 319, Issue 2, 2006, Pages 507-514

  Negus, S Stevens ^a   Vanderah, T W ^c   Brandt, M R ^d   Bilsky, E J ^e   Becerra, L ^a   Borsook, D ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^e UNIVERSITY OF NEW ENGLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ANALGESIC AGENT; ANTICONVULSIVE AGENT; FORMALDEHYDE; GABAPENTIN; HALOPERIDOL; IBUPROFEN; MORPHINE; MU OPIATE RECEPTOR AGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PACLITAXEL; REMIFENTANIL; STEROID; STREPTOZOCIN; VINCRISTINE;

ALLODYNIA; ANALGESIA; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG RESEARCH; DRUG SCREENING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HYPERALGESIA; INFLAMMATION; NERVE CONDUCTION; NEUROPATHIC PAIN; NEUROPATHY; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; OSTEOARTHRITIS; PAIN; PRIORITY JOURNAL; REVIEW;

ANALGESIA; ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; MICE; NEURALGIA; PAIN;

EID: 33751192096     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.106377     Document Type: Review

References (62)

1. Andersen AH, Zhang Z, Barber T, Rayens WS, Zhang J, Grondin R, Hardy P, Gerhardt GA, and Gash DM (2002) Functional MRI studies in awake rhesus monkeys: methodological and analytical strategies. J Neurosci Methods 118:141-152.
2. Backonja MM and Stacey B (2004) Neuropathic pain symptoms relative to overall pain rating. J Pain 5:491-497.
3. Bair MJ, Robinson RL, Katon W, and Kroenke K (2003) Depression and pain comorbidity: a literature review. Arch Intern Med 163:2433-2445.
4. Barbour H and Maurer L (1920) Tyramine as a morphine antagonist. J Pharmacol Exp Ther 15:305-330.
5. Bennett GJ (2001) Animal models of pain, in Methods in Pain Research (Kruger L ed), pp 67-91, CRC Press, Inc. Boca Raton, FL.
6. Bennett GJ and Xie YK (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33:87-107.
7. Blackburn-Munro G (2004) Pain-like behaviours in animals - how human are they? Trends Pharmacol Sci 25:299-305.
8. Borsook D and Becerra L (2003) Pain imaging: future applications to integrative clinical and basic neurobiology. Adv Drug Deliv Rev 55:967-986.
9. Borsook D, Ploghaus A, and Becerra L (2002) Utilizing brain imaging for analgesic drug development. Curr Opin Investig Drugs 3:1342-1347.
10. Calcutt N (2004) Modeling diabetic sensory neuropathy in rats, in Pain Research: Methods and Protocols (Luo Z ed) pp 55-65, Humana Press, Totowa, NJ.
11. Chesler EJ, Wilson SG, Lariviere WR, Rodriguez-Zas SL, and Mogil JS (2002) Identification and ranking of genetic and laboratory environment factors influencing a behavioral trait, thermal nociception, via computational analysis of a large data archive. Neurosci Biobehav Rev 26:907-923.
12. Coop A (2005) Biological evaluation of opioids, stimulants, and depressants. I. An overview of the studies performed by the Drug Evaluation Committee of the College on Problems of Drug Dependence. NIDA Res Monogr 185:105-130.
13. D'Amour F and Smith D (1940) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74-79.
14. da Silva Filho AA, Andrade e Silva ML, Carvalho JC, and Bastos JK (2004) Evaluation of analgesic and anti-inflammatory activities of Nectandra megapotamica (Lauraceae) in mice and rats. J Pharm Pharmacol 56:1179-1184.
15. Damas J and Liegeois JF (1999) The inflammatory reaction induced by formalin in the rat paw. Naunyn-Schmiedeberg's Arch Pharmacol 359:220-227.
16. Davis KD (2000) Studies of pain using functional magnetic resonance imaging, in Pain Imaging (Casey KL and Bushnell MC eds) pp 195-210, IASP Press, Seattle, WA.
17. Decosterd I and Woolf CJ (2000) Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87:149-158.
18. Dubuisson D and Dennis SG (1977) The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4:161-174.
19. Dykstra LA (1985) Behavioral and pharmacological factors in opioid analgesia, in Behavioral Pharmacology: The Current Status (Seiden LS and Balster RL eds) pp 111-129, Alan R. Liss, Inc., New York.
20. Fernihough J, Gentry C, Malcangio M, Fox A, Rediske J, Pellas T, Kidd B, Bevan S, and Winter J (2004) Pain related behaviour in two models of osteoarthritis in the rat knee. Pain 112:83-93.
21. Flecknell PA (1994) Refinement of animal use-assessment and alleviation of pain and distress. Lab Anim 28:222-231.
22. Fox A, Eastwood C, Gentry C, Manning D, and Urban L (1999) Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat. Pain 81:307-316.
23. Hess A, Sergejeva M, Budinsky L, Zeilhofer HU, and Brune K (2006) Imaging of hyperalgesia in rats by functional MRI. Eur J Pain, in press.
24. Higuera ES and Luo ZD (2004) A rat pain model of vincristine-induced neuropathy. Methods Mol Med 99:91-98.
25. Holmes PV (2003) Rodent models of depression: reexamining validity without anthropomorphic inference. Crit Rev Neurobiol 15:143-174.
26. Hunskaar S and Hole K (1987) The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30:103-114.
27. International Association for the Study of Pain (1979) Pain terms - a list with definitions and notes on usage. Pain 6:249-252.
28. Irving GA (2005) Contemporary assessment and management of neuropathic pain. Neurology 64:S21-S27.
29. Jasmin L, Kohan L, Franssen M, Janni G, and Goff JR (1998) The cold plate as a test of nociceptive behaviors: description and application to the study of chronic neuropathic and inflammatory pain models. Pain 75:367-382.
30. Jett MF, Ramesha CS, Brown CD, Chiu S, Emmett C, Voronin T, Sun T, O'Yang C, Hunter JC, Eglen RM, et al. (1999) Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat. J Pharmacol Exp Ther 288:1288-1297.
31. Karas AZ (2002) Postoperative analgesia in the laboratory mouse, Mus musculus. Lab Anim (NY) 31:49-52.
32. Kim SH and Chung JM (1992) An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50:355-363.
33. King JA, Garelick TS, Brevard ME, Chen W, Messenger TL, Duong TQ, and Ferris CF (2005) Procedure for minimizing stress for fMRI studies in conscious rats. J Neurosci Methods 148:154-160.
34. Kontinen V and Meert TF (2003) Predictive validity of neuropathic pain models in pharmacological studies with a behavioral outcome in the rat: a systematic review, in Proceedings of the 10th World Congress on Pain: Progress in Pain Research and Management (Dostrovsky J, Carr DB, and Koltzenburg M eds) pp 489-498, IASP Press, Seattle, WA.
35. Le Bars D, Gozariu M, and Cadden SW (2001) Animal models of nociception. Pharmacol Rev 53:597-652.
36. Luo ZD (2004) Mechanistic dissection of pain: from DNA to animal models. Methods Mol Med 99:1-10.
37. Malisza KL and Docherty JC (2001) Capsaicin as a source for painful stimulation in functional MRI. J Magn Reson Imaging 14:341-347.
38. Marchand F, Perretti M, and McMahon SB (2005) Role of the immune system in chronic pain. Nat Rev Neurosci 6:521-532.
39. Martin TJ, Buechler NL, Kahn W, Crews JC, and Eisenach JC (2004) Effects of laparotomy on spontaneous exploratory activity and conditioned operant responding in the rat: a model for postoperative pain. Anesthesiology 101:191-203.
40. Martin TJ and Eisenach JC (2001) Pharmacology of opioid and nonopioid analgesics in chronic pain states. J Pharmacol Exp Ther 299:811-817.
41. Mogil JS and Crager SE (2004) What should we be measuring in behavioral studies of chronic pain in animals? Pain 112:12-15.
42. Mogil JS, Wilson SG, and Wan Y (2001) Assessing nociception in murine subjects, in Methods in Pain Research (Kruger L ed) pp 11-39, CRC Press, Inc., Boca Raton, FL.
43. National Research Council (1996) Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington DC.
44. 2-induced thermal hyperalgesia and its reversal by morphine in the warm-water tail-withdrawal procedure in rhesus monkeys. J Pharmacol Exp Ther 266:1355-1363.
45. Ostelo RW and de Vet HC (2005) Clinically important outcomes in low back pain. Best Pract Res Clin Rheumatol 19:593-607.
46. Pomonis JD, Boulet JM, Gottshall SL, Phillips S, Sellers R, Bunton T, and Walker K (2005) Development and pharmacological characterization of a rat model of osteoarthritis pain. Pain 114:339-346.
47. Price DD (2002) Central neural mechanisms that interrelate sensory and affective dimensions of pain. Mol Interv 2:392-402.
48. Rodriguez L and Pardo EG (1974) Reversal by narcotics and narcotic antagonists of pain-induced functional impairment, in Narcotic Antagonists (Braude MC, Harris LS, May EL, Smith JP, and Villarreal JE eds) pp 213-223, Raven Press, New York.
49. Rodriguez R and Pardo EG (1968) Drug reversal of pain induced functional impairment. Arch Int Pharmacodyn Ther 172:148-160.
50. Seguin L, Le Marouille-Girardon S, and Millan MJ (1995) Antinociceptive profiles of non-peptidergic neurokinin1 and neurokinin2 receptor antagonists: a comparison to other classes of antinociceptive agent. Pain 61:325-343.
51. Seltzer Z, Dubner R, and Shir Y (1990) A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 43:205-218.
52. Shah YB, Haynes L, Prior MJ, Marsden CA, Morris PG, and Chapman V (2005) Functional magnetic resonance imaging studies of opioid receptor-mediated modulation of noxious-evoked BOLD contrast in rats. Psychopharmacology (Berl) 180:761-773.
53. Smolen JS, Aletaha D, and Keystone E (2005) Superior efficacy of combination therapy for rheumatoid arthritis: fact or fiction? Arthritis Rheum 52:2975-2983.
54. Stevenson GW, Bilsky EJ, and Negus SS (2006) Targeting pain-suppressed behaviors in preclinical assays of pain and analgesia: effects of morphine on acetic acid-suppressed feeding in C57BL/6J mice. J Pain 7:408-416.
55. Suzuki R, Chapman V, and Dickenson AH (1999) The effectiveness of spinal and systemic morphine on rat dorsal horn neuronal responses in the spinal nerve ligation model of neuropathic pain. Pain 80:215-228.
56. Taylor BK, Peterson MA, Roderick RE, Tate J, Green PG, Levine JO, and Basbaum AI (2000) Opioid inhibition of formalin-induced changes in plasma extravasation and local blood flow in rats. Pain 84:263-270.
57. Tracey I (2001) Pharmacological fMRI: a new tool for drug development in humans. J Pharm Pract 14:368-375.
58. Tuor UI, Malisza K, Foniok T, Papadimitropoulos R, Jarmasz M, Somorjai R, and Kozlowski P (2000) Functional magnetic resonance imaging in rats subjected to intense electrical and noxious chemical stimulation of the forepaw. Pain 87:315-324.
59. +-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki Rats. Life Sci 76:2655-2668.
60. Vinegar R, Truax JF, and Selph JL (1976) Quantitative comparison of the analgesic and anti-inflammatory activities of aspirin, phenacetin and acetaminophen in rodents. Eur J Pharmacol 37:23-30.
61. Whiteside GT, Boulet JM, and Walker K (2005) The role of central and peripheral mu opioid receptors in inflammatory pain and edema: a study using morphine and DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triaza- spiro[4.5]dec-3-yl]-acetic acid). J Pharmacol Exp Ther 314:1234-1240.
62. Wise RG, Rogers R, Painter D, Bantick S, Ploghaus A, Williams P, Rapeport G, and Tracey I (2002) Combining fMRI with a pharmacokinetic model to determine which brain areas activated by painful stimulation are specifically modulated by remifentanil. Neuroimage 16:999-1014.